Dr. Khalil is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Riverside Professional Building
606 24th Avenue South, Suite 106
Minneapolis, MN 55454Phone+1 612-624-0999
Summary
- Dr. Wajahat Khalil is a Pulmonary, Critical Care and Sleep Medicine specialist in Minneapolis, MN and is affiliated with M Health Fairview and University of Minnesota. He received his medical degree from Baqai Medical and Dental College and has been in practice 21 years. He specializes in critical care medicine, pleural disease, and sleep medicine. He has 9 publications and over 250 citings.
Education & Training
- University of MinnesotaFellowship, Pulmonary Disease and Critical Care Medicine, 2005 - 2008
- Michael Reese Hospital and Medical CenterResidency, Internal Medicine, 2003 - 2005
- Baqai Medical and Dental CollegeClass of 1999
Certifications & Licensure
- MI State Medical License 2021 - 2027
- NE State Medical License 2008 - 2026
- MN State Medical License 2007 - 2025
- IL State Medical License 2005 - 2008
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
- American Board of Internal Medicine Sleep Medicine
Publications & Presentations
PubMed
- 12 citationsSleep Apnea Symptoms as a Predictor of Fatigue in an Urban HIV ClinicUmesh Goswami, Jason V. Baker, Qi Wang, Wajahat Khalil, Ken M. Kunisaki
AIDS Patient Care and Stds. 2015-10-27 - 124 citationsPathologic caveolin-1 regulation of PTEN in idiopathic pulmonary fibrosis.Hong Xia, Wajahat Khalil, Judy Kahm, Jose Jessurun, Jill Kleidon
The American Journal of Pathology. 2010-06-01 - 24 citationsInitial Recovery and Rebound of Type F Intestinal Colonization Botulism After Administration of Investigational Heptavalent Botulinum AntitoxinRyan P. Fagan, Karen P. Neil, Randy Sasich, Carolina Lúquez, Hakam Asaad
Clinical Infectious Diseases. 2011-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: